Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Bardia, Aditya, Mayer, Ingrid A, Vahdat, Linda T, Tolaney, Sara M, Isakoff, Steven J, Diamond, Jennifer R, O’Shaughnessy, Joyce, Moroose, Rebecca L, Santin, Alessandro D, Abramson, Vandana G, Shah, Nikita C, Rugo, Hope S, Goldenberg, David M, Sweidan, Ala M, Iannone, Robert, Washkowitz, Sarah, Sharkey, Robert M, Wegener, William A, Kalinsky, Kevin
Published in The New England journal of medicine (21.02.2019)
Published in The New England journal of medicine (21.02.2019)
Get full text
Journal Article
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
Starodub, Alexander N, Ocean, Allyson J, Shah, Manish A, Guarino, Michael J, Picozzi, Jr, Vincent J, Vahdat, Linda T, Thomas, Sajeve S, Govindan, Serengulam V, Maliakal, Pius P, Wegener, William A, Hamburger, Steven A, Sharkey, Robert M, Goldenberg, David M
Published in Clinical cancer research (01.09.2015)
Published in Clinical cancer research (01.09.2015)
Get full text
Journal Article
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
Dörner, Thomas, Kaufmann, Joerg, Wegener, William A, Teoh, Nick, Goldenberg, David M, Burmester, Gerd R
Published in Arthritis research & therapy (01.01.2006)
Published in Arthritis research & therapy (01.01.2006)
Get full text
Journal Article
Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study
RAETZ, Elizabeth A, CAIRO, Mitchell S, ADAMSON, Peter C, BOROWITZ, Michael J, BLANEY, Susan M, KRAILO, Mark D, LEIL, Tarek A, REID, Joel M, GOLDENBERG, David M, WEGENER, William A, CARROLL, William L
Published in Journal of clinical oncology (01.08.2008)
Published in Journal of clinical oncology (01.08.2008)
Get full text
Journal Article
Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results
MORSCHHAUSER, Franck, LEONARD, John P, WEGENER, William A, GOLDENBERG, David M, FAYAD, Luis, COIFFIER, Bertrand, PETILLON, Marie-Odile, COLEMAN, Morton, SCHUSTER, Stephen J, DYER, Martin J. S, HORNE, Heather, TEOH, Nick
Published in Journal of clinical oncology (10.07.2009)
Published in Journal of clinical oncology (10.07.2009)
Get full text
Journal Article
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
Steinfeld, Serge D, Tant, Laure, Burmester, Gerd R, Teoh, Nick K W, Wegener, William A, Goldenberg, David M, Pradier, Olivier
Published in Arthritis research & therapy (01.01.2006)
Published in Arthritis research & therapy (01.01.2006)
Get full text
Journal Article
High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
MORSCHHAUSER, Franck, KRAEBER-BODERE, Françoise, NAUMANN, Ralph, KROPP, Joachim, HORNE, Heather, TEOH, Nick, LE GOUILL, Steven, BODET-MILIN, Caroline, CHATAL, Jean-Francois, GOLDENBERG, David M, WEGENER, William A, HAROUSSEAU, Jean-Luc, PETILLON, Marie-Odile, HUGLO, Damien, TRÜMPER, Lorenz H, MELLER, Johannes, PFREUNDSCHUH, Michael, KIRSCH, Carl-Martin
Published in Journal of clinical oncology (10.08.2010)
Published in Journal of clinical oncology (10.08.2010)
Get full text
Journal Article
Low‐dose anti‐CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study
Liebman, Howard A., Saleh, Mansoor N., Bussel, James B., Negrea, Ovidiu George, Horne, Heather, Wegener, William A., Goldenberg, David M.
Published in British journal of haematology (01.09.2013)
Published in British journal of haematology (01.09.2013)
Get full text
Journal Article
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
Liebman, Howard A, Saleh, Mansoor N, Bussel, James B, Negrea, O George, Horne, Heather, Wegener, William A, Goldenberg, David M
Published in Haematologica (Roma) (01.11.2016)
Published in Haematologica (Roma) (01.11.2016)
Get full text
Journal Article
Multicenter Phase II Trial of Immunotherapy With the Humanized Anti-CD22 Antibody, Epratuzumab, in Combination With Rituximab, in Refractory or Recurrent Non-Hodgkin's Lymphoma
STRAUSS, Sandra J, MORSCHHAUSER, Frank, TEOH, Nick K. W, GOLDENBERG, David M, LISTER, T. Andrew, RECH, Juergen, REPP, Roland, SOLAL-CELIGNY, Philippe, ZINZANI, Pier L, ENGERT, Andreas, COIFFIER, Bernard, HOELZER, Dieter F, WEGENER, William A
Published in Journal of clinical oncology (20.08.2006)
Published in Journal of clinical oncology (20.08.2006)
Get full text
Journal Article
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study
Chevallier, Patrice, Huguet, Francoise, Raffoux, Emmanuel, Etienne, Anne, Leguay, Thibaut, Isnard, Francoise, Robillard, Nelly, Guillaume, Thierry, Delaunay, Jacques, Charbonnier, Aude, Pigneux, Arnaud, Peterlin, Pierre, Bené, Marie C, Wegener, William A, Goldenberg, David M, Dombret, Hervé
Published in Haematologica (Roma) (01.04.2015)
Published in Haematologica (Roma) (01.04.2015)
Get full text
Journal Article
Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma
LEONARD, John P, COLEMAN, Morton, KOVACS, Jacqueline, DING, Cliff L, WEGENER, William A, HORAK, Ivan D, GOLDENBERG, David M, KETAS, Jamie, ASHE, Michelle, FIORE, Jennifer M, FURMAN, Richard R, NIESVIZKY, Ruben, SHORE, Tsiporah, CHADBURN, Amy, HOME, Heather
Published in Journal of clinical oncology (01.08.2005)
Published in Journal of clinical oncology (01.08.2005)
Get full text
Journal Article
Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma
LEONARD, John P, COLEMAN, Morton, GAYKO, Urte, CESANO, Alessandra, GOLDENBERG, David M, KETAS, Jamie C, CHADBURN, Amy, ELY, Scott, FURMAN, Richard R, WEGENER, William A, HANSEN, Hans J, ZICCARDI, Heather, ESCHENBERG, Michael
Published in Journal of clinical oncology (15.08.2003)
Published in Journal of clinical oncology (15.08.2003)
Get full text
Journal Article
Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia
Chevallier, Patrice, Chantepie, Sylvain, Huguet, Francoise, Raffoux, Emmanuel, Thomas, Xavier, Leguay, Thibaut, Marchand, Tony, Isnard, Francoise, Charbonnier, Aude, Maury, Sébastien, Gallego-Hernanz, Maria-Pilar, Robillard, Nelly, Guillaume, Thierry, Peterlin, Pierre, Garnier, Alice, Rialland, Fanny, Le Houerou, Claire, Goldenberg, David M, Wegener, William A, Béné, Marie-C, Dombret, Hervé
Published in Haematologica (Roma) (01.05.2017)
Published in Haematologica (Roma) (01.05.2017)
Get full text
Journal Article
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin’s lymphoma
NEGREA, George O, ELSTROM, Rebecca, ALLEN, Steven L, RAI, Kanti R, ABBASI, Rashid M, FARBER, Charles M, TEOH, Nick, HORNE, Heather, WEGENER, William A, GOLDENBERG, David M
Published in Haematologica (Roma) (01.04.2011)
Published in Haematologica (Roma) (01.04.2011)
Get full text
Journal Article
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
Wallace, Daniel J, Figueras, Florence, Wegener, William A, Goldenberg, David M
Published in Annals of the rheumatic diseases (01.07.2021)
Published in Annals of the rheumatic diseases (01.07.2021)
Get full text
Journal Article
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Bardia, Aditya, Mayer, Ingrid A, Diamond, Jennifer R, Moroose, Rebecca L, Isakoff, Steven J, Starodub, Alexander N, Shah, Nikita C, O'Shaughnessy, Joyce, Kalinsky, Kevin, Guarino, Michael, Abramson, Vandana, Juric, Dejan, Tolaney, Sara M, Berlin, Jordan, Messersmith, Wells A, Ocean, Allyson J, Wegener, William A, Maliakal, Pius, Sharkey, Robert M, Govindan, Serengulam V, Goldenberg, David M, Vahdat, Linda T
Published in Journal of clinical oncology (01.07.2017)
Published in Journal of clinical oncology (01.07.2017)
Get full text
Journal Article
Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics
Ocean, Allyson J., Starodub, Alexander N., Bardia, Aditya, Vahdat, Linda T., Isakoff, Steven J., Guarino, Michael, Messersmith, Wells A., Picozzi, Vincent J., Mayer, Ingrid A., Wegener, William A., Maliakal, Pius, Govindan, Serengulam V., Sharkey, Robert M., Goldenberg, David M.
Published in Cancer (01.10.2017)
Published in Cancer (01.10.2017)
Get full text
Journal Article
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Heist, Rebecca Suk, Guarino, Michael J, Masters, Gregory, Purcell, W Thomas, Starodub, Alexander N, Horn, Leora, Scheff, Ronald J, Bardia, Aditya, Messersmith, Wells A, Berlin, Jordan, Ocean, Allyson J, Govindan, Serengulam V, Maliakal, Pius, Mudenda, Boyd, Wegener, William A, Sharkey, Robert M, Goldenberg, David M, Camidge, D Ross
Published in Journal of clinical oncology (20.08.2017)
Published in Journal of clinical oncology (20.08.2017)
Get full text
Journal Article
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma
Witzig, Thomas E, Tomblyn, Michael B, Misleh, Jamal G, Kio, Ebenezer A, Sharkey, Robert M, Wegener, William A, Goldenberg, David M
Published in Haematologica (Roma) (01.11.2014)
Published in Haematologica (Roma) (01.11.2014)
Get full text
Journal Article